REGENERON PHARMACEUTICALS INC (NASDAQ: REGN)

Overview
current price
$571.32
$571.32
change
-2.84 | -0.50%
-2.84 | -0.50%
Yesterday's Close
574.16
open
576.35
volume
0.83 M
30d. avg volume.
1.32 M
1 day
568.19 - 580.56
52 weeks
520.50 - 1,211.20
p/e
14.59
beta
0.4267
market cap
60.95 B
dividend yield
0.61%
Industry
-
News and Commentary
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst Wednesday, Johnson & Johnson (...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
$1 Billion Deal For Moderna To Expand Product Pipeline In China The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in...
FDA Pulls Authorization for GSK Antibody Drug Ineffective Against New Omicron Strain The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for GlaxoSmithKline plc's
FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron
Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron
October 26 Market Update Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the British FTSE rose 0.76%, the German DAX climbed 1.01%, the French CAC rose...
AstraZeneca's Antibody Therapy is 77% Effective at Preventing COVID Symptoms in Late-Stage Trial AstraZeneca's (AZN&nbsp...
StockTwits
StockTwits